American Healthcare REIT (NYSE:AHR – Get Free Report) will likely be issuing its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect American Healthcare REIT to post earnings of $0.1372 per share and revenue of $669.0890 million for the quarter. American Healthcare REIT has set its FY 2026 guidance at 2.030-2.090 EPS. Interested persons may visit the the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Friday, August 7, 2026 at 1:00 PM ET.
American Healthcare REIT (NYSE:AHR – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.34). The company had revenue of $650.77 million for the quarter, compared to analyst estimates of $667.57 million. American Healthcare REIT had a net margin of 4.23% and a return on equity of 3.33%. The company’s revenue was up 20.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.38 EPS. On average, analysts expect American Healthcare REIT to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
American Healthcare REIT Trading Down 0.2%
Shares of AHR stock opened at $57.61 on Thursday. The firm’s 50-day simple moving average is $51.42 and its 200-day simple moving average is $50.34. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.45 and a quick ratio of 0.45. American Healthcare REIT has a 1-year low of $37.66 and a 1-year high of $58.70. The firm has a market cap of $11.10 billion, a P/E ratio of 99.33, a PEG ratio of 1.93 and a beta of 0.77.
American Healthcare REIT Dividend Announcement
Insiders Place Their Bets
In related news, EVP Mark E. Foster sold 2,500 shares of the stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $48.58, for a total value of $121,450.00. Following the completion of the sale, the executive vice president directly owned 52,995 shares in the company, valued at approximately $2,574,497.10. This represents a 4.50% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Brian Peay sold 25,000 shares of the firm’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $50.70, for a total value of $1,267,500.00. Following the completion of the transaction, the chief financial officer directly owned 152,700 shares in the company, valued at $7,741,890. This trade represents a 14.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 29,500 shares of company stock worth $1,485,590. Insiders own 0.75% of the company’s stock.
Institutional Investors Weigh In On American Healthcare REIT
Several hedge funds have recently modified their holdings of AHR. Invesco Ltd. grew its position in American Healthcare REIT by 3.3% in the fourth quarter. Invesco Ltd. now owns 5,531,582 shares of the company’s stock valued at $260,316,000 after acquiring an additional 177,033 shares in the last quarter. Corient Private Wealth LLC lifted its position in shares of American Healthcare REIT by 28.1% during the fourth quarter. Corient Private Wealth LLC now owns 7,778 shares of the company’s stock worth $366,000 after purchasing an additional 1,708 shares in the last quarter. Mercer Global Advisors Inc. ADV boosted its stake in shares of American Healthcare REIT by 177.2% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 21,529 shares of the company’s stock valued at $1,013,000 after purchasing an additional 13,762 shares during the period. EP Wealth Advisors LLC purchased a new position in shares of American Healthcare REIT in the fourth quarter valued at $257,000. Finally, Garton & Associates Financial Advisors LLC acquired a new stake in American Healthcare REIT during the 4th quarter valued at $26,000. 16.68% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
AHR has been the topic of a number of recent analyst reports. Scotiabank cut their price target on shares of American Healthcare REIT from $59.00 to $51.00 and set a “sector outperform” rating on the stock in a research note on Thursday, June 18th. Barclays initiated coverage on shares of American Healthcare REIT in a research note on Tuesday, July 7th. They set an “overweight” rating and a $61.00 price objective for the company. UBS Group upped their price objective on American Healthcare REIT from $60.00 to $63.00 and gave the stock a “buy” rating in a report on Wednesday, July 8th. Royal Bank Of Canada lifted their target price on American Healthcare REIT from $54.00 to $56.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Finally, Citizens Jmp boosted their price target on American Healthcare REIT from $60.00 to $65.00 and gave the company a “market outperform” rating in a research report on Monday. Twelve equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $58.83.
View Our Latest Analysis on AHR
About American Healthcare REIT
American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.
Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.
Recommended Stories
- Five stocks we like better than American Healthcare REIT
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
